Pain Control After Arthroscopic Shoulder Surgeries

Not Applicable

Completed

• Conditions: Post Operative Pain
• Interventions: Procedure: Ultrasound-guided Interscalene Block group; Procedure: Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block; Drug: Bupivacaine

• Registration Number: NCT05686395
• Lead Sponsor: Tanta University

Brief Summary

This study will be conducted to compare the perioperative analgesic efficacy of ultrasound - guided interscalene brachial plexus block versus combined shoulder anterior capsular block and anterior suprascapular nerve block for arthroscopic shoulder surgeries.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-01-06
• Study First Submitted QC: 2023-01-13
• Study First Posted: 2023-01-17
• Study Start: 2023-01-23
• Primary Completion: 2024-08-11
• Study Completion: 2024-08-11
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-16
• Last Update Posted: 2024-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patients aged 20-65 years of both sexes, with American Society of Anesthesiologists (ASA) physical status I or II admitted for arthroscopic shoulder surgery.

Exclusion Criteria

• Patient refusal.
• Uncooperative patient.
• Patient with neurological deficit.
• Patients with respiratory disorders.
• Patient with bleeding disorders.
• Infection at the block injection site.
• Patients with history of allergy to local anesthetics.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
group 1 Ultrasound-guided Interscalene Block group	Ultrasound-guided Interscalene Block group	In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.
group 1 Ultrasound-guided Interscalene Block group	Bupivacaine	In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.
group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block	Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block	, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.
group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block	Bupivacaine	, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.

Primary Outcome Measures

Name	Time	Method
post operative analgesic consumption	24 hours after surgery	The first 24 hours post operative analgesic consumption

Secondary Outcome Measures

Name	Time	Method
Visual Analogue score (VAS) in the first 24 hours after surgery	first 24 hours after surgery	- Postoperative pain intensity will be assessed in the first 24 hour using VAS score where (0 = no pain and 100 = the worst imaginable pain)
Patient satisfaction score	first 24 hours after surgery	Patient satisfaction score will be assessed on the basis of a questionnaire and graded on a 4-point scale (excellent/good/fair/poor).
The incidence of hemi diaphragmatic paralysis	immediately before block and immediately after procedure	hemidiaphragmatic paralysis after block

Trial Locations

Locations (1)

Faculty of Medicine Tanta University; 🇪🇬 Tanta, Egypt